Read This Before Selling Meilleure Health International Industry Group Limited (HKG:2327) Shares

It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So shareholders might well want to know whether insiders have been buying or selling shares in Meilleure Health International Industry Group Limited (HKG:2327).

Do Insider Transactions Matter?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern insider transactions, and certain disclosures are required.

Insider transactions are not the most important thing when it comes to long-term investing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Columbia University study found that ‘insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers’.

View our latest analysis for Meilleure Health International Industry Group

Meilleure Health International Industry Group Insider Transactions Over The Last Year

Chairman Xuzhou Zhou made the biggest insider purchase in the last 12 months. That single transaction was for HK$2.9m worth of shares at a price of HK$0.39 each. So it’s clear an insider wanted to buy, even at a higher price. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company’s future. We generally consider it a positive if insiders have been buying on market, even above the current price.

In the last twelve months insiders paid HK$20m for 51.82m shares purchased. In total, Meilleure Health International Industry Group insiders bought more than they sold over the last year. They paid about HK$0.39 on average. I’d consider this a positive as it suggests insiders see value at around the current price, which is HK$0.39. You can see the insider transactions (by individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

SEHK:2327 Insider Trading January 8th 19
SEHK:2327 Insider Trading January 8th 19

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insiders at Meilleure Health International Industry Group Have Bought Stock Recently

Over the last three months, we’ve seen significant insider buying at Meilleure Health International Industry Group. Not only was there no selling that we can see, but they collectively bought HK$1.6m worth of shares. This could be interpreted as suggesting a positive outlook.

Insider Ownership

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Our data indicates that Meilleure Health International Industry Group insiders own about HK$47m worth of shares (which is 3.2% of the company). But they may have an indirect interest through a corporate structure that we haven’t picked up on. Overall, this level of ownership isn’t that impressive, but it’s certainly better than nothing!

What Might The Insider Transactions At Meilleure Health International Industry Group Tell Us?

The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. Given that insiders also own a fair bit of Meilleure Health International Industry Group we think they are probably pretty confident of a bright future. I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.

Of course Meilleure Health International Industry Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.